Prenylation of Rho G-proteins: A novel mechanism regulating gene expression and protein stability in human trabecular meshwork cells

Molecular Neurobiology

Volumn 46, Issue 1, 2012, Pages 28-40

  Stubbs Jr , Evan B ^a,b   Von Zee, Cynthia L ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

G proteins; Isoprenoids; Rho; Trabecular meshwork

Indexed keywords

DITERPENE; ISOPRENOID; PROTEASOME; PROTEIN FARNESYLTRANSFERASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; SESQUITERPENE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRENYLATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; TRABECULAR MESHWORK;

EID: 84868126101     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8249-x     Document Type: Article

References (58)

1. Holstein SA, Hohl RJ (2004) Isoprenoids: remarkable diversity of form and function. Lipids 39:293-309 (Pubitemid 38971743)
2. Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241-269 (Pubitemid 26250610)
3. Zhang L, Tschantz WR, Casey PJ (1997) Isolation and characterization of a prenylcysteine lyase from bovine brain. J Biol Chem 272:23354-23359 (Pubitemid 27392475)
4. Gao J, Liao J, Yang GY (2009) CAAX-box protein, prenylation process and carcinogenesis. Am J Transl Res 1:312-325
5. Wright LP, Philips MR (2006) Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J Lipid Res 47:883-891
6. Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116:167-179 (Pubitemid 38167310)
7. Mackay DJ, Hall A (1998) Rho GTPases. J Biol Chem 273:20685-20688 (Pubitemid 28385341)
8. Wheeler AP, Ridley AJ (2004) Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301:43-49 (Pubitemid 39388895)
9. Roberts PJ, Mitin N, Keller PJ et al (2008) Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J Biol Chem 283:25150-25163
10. Dietrich LE, Ungermann C (2004) On the mechanism of protein palmitoylation. EMBO Rep 5:1053-1057 (Pubitemid 39600203)
11. Smotrys JE, Linder ME (2004) Palmitoylation of intracellular signaling proteins: regulation and function. Annu Rev Biochem 73:559-587 (Pubitemid 39050380)
12. Alm A, Nilsson SF (2009) Uveoscleral outflow-A review. Exp Eye Res 88:760-768
13. Tian B, Gabelt BT, Geiger B, Kaufman PL (2009) The role of the actomyosin system in regulating trabecular fluid outflow. Exp Eye Res 88:713-717
14. Ramachandran C, Satpathy M, Mehta D, Srinivas SP (2008) Forskolin induces myosin light chain dephosphorylation in bovine trabecular meshwork cells. Curr Eye Res 33:169-176 (Pubitemid 351302199)
15. Shen X, Koga T, Park BC, SundarRaj N, Yue BY (2008) Rho GTPase and cAMP/protein kinase A signaling mediates myocilininduced alterations in cultured human trabecular meshwork cells. J Biol Chem 283:603-612
16. Rao VP, Epstein DL (2007) Rho GTPase/Rho kinase inhibition Abstract: A novel target for the treatment of glaucoma. BioDrugs 21:167-177 (Pubitemid 46827850)
17. Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, Yue BY, Narumiya S, Honda Y (2001) Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci 42:137-144 (Pubitemid 32059420)
18. Liu X, Hu Y, Filla MS, Gabelt BT, Peters DM, Brandt CR, Kaufman PL (2005) The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis 11:1112-1121 (Pubitemid 41819512)
19. Nakamura Y, Hirano S, Suzuki K, Seki K, Sagara T, Nishida T (2002) Signaling mechanism of TGF-beta1-induced collagen contraction mediated by bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci 43:3465-3472 (Pubitemid 35334354)
20. Rao PV, Deng P, Maddala R, Epstein DL, Li CY, Shimokawa H (2005) Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow. Mol Vis 11:288-297 (Pubitemid 41358280)
21. Rao PV, Deng PF, Kumar J, Epstein DL (2001) Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci 42:1029-1037 (Pubitemid 32289800)
22. Thieme H, Nuskovski M, Nass JU, Pleyer U, Strauss O, Wiederholt M (2000) Mediation of calcium-independent contraction in trabecular meshwork through protein kinase C and rho-A. Invest Ophthalmol Vis Sci 41:4240-4246
23. Liao JK, Seto M, Noma K (2007) Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 50:17-24 (Pubitemid 47220442)
24. Tanihara H, Inatani M, Honjo M, Tokushige H, Azuma J, Araie M (2008) Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Arch Ophthalmol 126:309-315 (Pubitemid 351398453)
25. Sever N, Song BL, Yabe D, Goldstein JL, BrownMS, DeBose-Boyd RA (2003) Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3- methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem 278:52479-52490 (Pubitemid 38035841)
26. Holstein SA, Wohlford-Lenane CL, Hohl RJ (2002) Isoprenoids influence expression of Ras and Ras-related proteins. Biochemistry 41:13698-13704 (Pubitemid 35332707)
27. Holstein SA, Wohlford-Lenane CL, Hohl RJ (2002) Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB. J Biol Chem 277:10678-10682 (Pubitemid 34968195)
28. Von Zee CL, Richards MP, Bu P, Perlman JI, Stubbs EB (2009) Lovastatin increases RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci
29. Von Zee CL, Stubbs EB Jr (2011) Geranylgeranylation facilitates proteasomal degradation of rho G-proteins in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 52:1676-1683
30. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227-239 (Pubitemid 38924592)
31. Laufs U, Liao JK (2000) Targeting Rho in cardiovascular disease. Circ Res 87:526-528
32. Adamson P, Marshall CJ, Hall A, Tilbrook PA (1992) Posttranslational modifications of p21rho proteins. J Biol Chem 267:20033-20038
33. Armstrong SA, Hannah VC, Goldstein JL, Brown MS (1995) CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB. J Biol Chem 270:7864-7868
34. Lebowitz PF, Du W, Prendergast GC (1997) Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription. J Biol Chem 272:16093-16095 (Pubitemid 27276421)
35. Allal C, Favre G, Couderc B, Salicio S, Sixou S, Hamilton AD, Sebti SM, Lajoie-Mazenc I, Pradines A (2000) RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem 275:31001-31008
36. Cole SL, Vassar R (2006) Isoprenoids and Alzheimer's disease: A complex relationship. Neurobiol Dis 22:209-222
37. Hooff GP, Wood WG, Muller WE, Eckert GP (2010) Isoprenoids, small GTPases and Alzheimer's disease. Biochim Biophys Acta 1801:896-905
38. Pac-Soo C, Lloyd DG, Vizcaychipi MP, Ma D (2011) Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration. J Alzheimers Dis 27:1-10
39. Piau A, Nourhashemi F, Hein C, Caillaud C, Vellas B (2011) Progress in the development of new drugs in Alzheimer's disease. J Nutr Health Aging 15:45-57
40. Li L, Cao D, Kim H, Lester R, Fukuchi K (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol 60:729-739 (Pubitemid 46061359)
41. Mans RA, Chowdhury N, Cao D, McMahon LL, Li L (2010) Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice. Neuroscience 166:435-444
42. Yue BY, Higginbotham EJ, Chang IL (1990) Ascorbic acid modulates the production of fibronectin and laminin by cells from an eye tissue-trabecular meshwork. Exp Cell Res 187:65-68
43. Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Bohm M (2000) Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 102:3104-3110
44. Correll CC, Ng L, Edwards PA (1994) Identification of farnesol Abstract: the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 269:17390-17393
45. Stamatakis K, Cernuda-Morollon E, Hernandez-Perera O, Perez- Sala D (2002) Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway. J Biol Chem 277:49389-49396 (Pubitemid 36014371)
46. Pang IH, Shade DL, Clark AF, Steely HT, DeSantis L (1994) Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res 13:51-63 (Pubitemid 24053155)
47. Rolli-Derkinderen M, Sauzeau V, Boyer L, Lemichez E, Baron C, Henrion D, Loirand G, Pacaud P (2005) Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ Res 96:1152-1160 (Pubitemid 40827690)
48. Liton PB, Gonzalez P, Epstein DL (2009) The role of proteolytic cellular systems in trabecular meshwork homeostasis. Exp Eye Res 88:724-728
49. Hanna J, Finley D (2007) A proteasome for all occasions. FEBS Lett 581:2854-2861 (Pubitemid 46874384)
50. Boyer L, Turchi L, Desnues B et al (2006) CNF1-induced ubiquitylation and proteasome destruction of activated RhoA is impaired in Smurf1-/- cells. Mol Biol Cell 17:2489-2497 (Pubitemid 43825488)
51. Chen Y, Yang Z, Meng M et al (2009) Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol Cell 35:841-855
52. Breusing N, Grune T (2008) Regulation of proteasome-mediated protein degradation during oxidative stress and aging. Biol Chem 389:203-209 (Pubitemid 351329027)
53. Perez-Sala D, Boya P, Ramos I, Herrera M, Stamatakis K (2009) The C-terminal sequence of RhoB directs protein degradation through an endo-lysosomal pathway. PLoS One 4:e8117
54. Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K (1997) Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275:1308-1311 (Pubitemid 27114159)
55. Waki M, Yoshida Y, Oka T, Azuma M (2001) Reduction of intraocular pressure by topical administration of an inhibitor of the Rho-associated protein kinase. Curr Eye Res 22:470-474 (Pubitemid 34253206)
56. Song J, Deng PF, Stinnett SS, Epstein DL, Rao PV (2005) Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci 46:2424-2432 (Pubitemid 43119489)
57. Vittitow JL, Garg R, Rowlette LL, Epstein DL, O'Brien ET, Borras T (2002) Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures. Mol Vis 8:32-44 (Pubitemid 36153588)
58. McGwin G Jr, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP (2004) Statins and other cholesterol-lowering medications and the presence of glaucoma. Arch Ophthalmol 122:822-826 (Pubitemid 38736240)